Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DURVALUMAB vs EDETATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DURVALUMAB vs EDETATE: Safety Overview

Metric DURVALUMAB EDETATE
Total FAERS Reports 17,142 145
Deaths Reported 5,088 9
Death Rate 29.7% 6.2%
Hospitalizations 5,968 107
Average Patient Age 65.7 yrs 58.2 yrs
% Female Patients 35.1% 51.1%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer AstraZeneca Pharmaceuticals LP Rising Pharma Holdings, Inc.
Route INTRAVENOUS INTRAMUSCULAR
Marketing Status Prescription Discontinued